Evidence map›Paper›PMID 37339207›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.

Maryamsadat Seyedsadr, Yan Wang, Manal Elzoheiry, Sowmya Shree Gopal, Soohwa Jang, Gayel Duran, Inna Chervoneva, Ezgi Kasimoglou, John A Wrobel, Daniel Hwang and 10 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The role of IL-11 in chronic diseases.Frontiers in immunology · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Astrocytic abnormalities in brain-specificChannels (Austin, Tex.) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Maryamsadat SeyedsadrDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.
Yan WangDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.
Manal ElzoheiryDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-5756-3651
Sowmya Shree GopalDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.
Soohwa JangDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-7962-1138
Gayel DuranBiomedical Research Institute, Department of Immunology, Hasselt University, Hasselt 3590, Belgium.ORCID 0000-0002-9910-5093
Inna ChervonevaDepartment of Pharmacology, Biostatistics, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107.
Ezgi KasimoglouDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.
John A WrobelLinberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0002-5828-9359
Daniel HwangDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-6071-8271
James GarifallouCenter for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Xin ZhangDepartment of Orthopedic Surgery, Duke University, Durham, NC 27599.ORCID 0000-0001-7390-4439
Tabish H KhanDivison of Laboratory and Genomic Medicine, Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-0143-7496
Ulrike LorenzDivison of Laboratory and Genomic Medicine, Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110.ORCID 0000-0002-7933-6855
Maureen SuDepartment of Microbiology, Immunology and Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095.ORCID 0000-0002-3680-9982
Jenny P TingLinberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599.ORCID 0000-0003-4398-5164
Bieke BrouxBiomedical Research Institute, Department of Immunology, Hasselt University, Hasselt 3590, Belgium.
Abdolmohamad RostamiDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.
Dhanashri MiskinDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.
Silva Markovic-PleseDepartment of Neurology, Neuroimmunology Division, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-0061-2707
Thomas Jefferson University · USHasselt University · BEUniversity of North Carolina at Chapel Hill · USWashington University in St. Louis · USChildren's Hospital of Philadelphia · USDuke University · USUniversity of California, Los Angeles · US

Funding

Molecular and Functional Analysis of NLR Family MembersR01AI029564 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jenny P Ting · 1991 to 2026
$6.0M
Autoimmune Mechanisms in Peripheral NeuropathyR01NS107851 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCHERER, STEVEN SIMON, SU, MAUREEN A · 2018 to 2021
$2.0M
The Role of IL-II in the development of autoimmune response in multiple sclerosisR01AI131238 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI MARKOVIC-PLESE, SILVA · 2018 to 2022
$2.0M
Epigenetic Mechanisms in Type 1 DiabetesR01DK119445 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SU, MAUREEN A · 2020 to 2023
$1.5M
NIAID NIH HHS R01 AI029564NIAID NIH HHS R01 AI131238NIDDK NIH HHS R01 DK119445NINDS NIH HHS R01 NS107851
6 · The paper itself

Abstract

The objective of this study is to examine IL-11-induced mechanisms of inflammatory cell migration to the central nervous system (CNS). We report that IL-11 is produced at highest frequency by myeloid cells among the peripheral blood mononuclear cell (PBMC) subsets. Patients with relapsing-remitting multiple sclerosis (RRMS) have an increased frequency of IL-11

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalInflammasomesAnimalsCell MovementCentral Nervous SystemInterleukin-11Leukocytes, MononuclearMiceMonocytesNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesInterleukin-11NLR Family, Pyrin Domain-Containing 3 ProteinEAEIL-11monocytemultiple sclerosisNLRP3 inflammasome

Identifiers

PMID37339207
PMCPMC10293805
OpenAlexW4381430561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.